Tower Research Capital LLC (TRC) - OPIANT PHARMACEUTICALS INC ownership

OPIANT PHARMACEUTICALS INC's ticker is OPNT and the CUSIP is 683750103. A total of 31 filers reported holding OPIANT PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of OPIANT PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$15
-99.6%
744
+71.4%
0.00%
Q3 2022$4,000
-75.0%
434
-68.3%
0.00%
Q2 2022$16,000
+433.3%
1,369
+789.0%
0.00%
Q1 2022$3,000
-25.0%
154
+11.6%
0.00%
Q3 2021$4,000
+33.3%
138
-46.5%
0.00%
Q2 2021$3,0000.0%258
-8.8%
0.00%
Q1 2021$3,000
-57.1%
283
-69.1%
0.00%
Q4 2020$7,000
+133.3%
916
+187.1%
0.00%
Q3 2020$3,000
-91.2%
319
-91.4%
0.00%
-100.0%
Q2 2020$34,0003,7270.00%
Other shareholders
OPIANT PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
HealthInvest Partners AB 210,000$2,518,0005.80%
APIS CAPITAL ADVISORS, LLC 196,000$2,350,0002.65%
Stonepine Capital Management, LLC 152,278$1,826,0000.85%
Parkman Healthcare Partners LLC 75,632$907,0000.33%
PERRITT CAPITAL MANAGEMENT INC 30,500$366,0000.22%
ESSEX INVESTMENT MANAGEMENT CO LLC 50,405$604,0000.10%
ACADIAN ASSET MANAGEMENT LLC 126,978$1,523,0000.01%
Trexquant Investment LP 12,219$147,0000.01%
Renaissance Technologies 193,415$2,319,0000.00%
TWO SIGMA ADVISERS, LP 74,400$892,0000.00%
View complete list of OPIANT PHARMACEUTICALS INC shareholders